Insulin Delivery Devices Market
Analysis and Future Forecast
Publisher: Renub Research
Published: June, 2009
Report Details
Insulin Delivery Devices Market Analysis and Future Forecast published by Renub Research
gives a detailed analysis on the global insulin market. The report analyses and forecast on
market size of different insulin delivery devices i.e. global insulin pen market, insulin pump
market, insulin syringe market and insulin jet injector market. The report investigates insulin
delivery devices market on the country level as well. Countries covered in the report are: for
Insulin pen market – US, Europe, India and Japan; Insulin pump market – US and India; Insulin
syringe market – US and India; Insulin jet injector market – US.
After analyzing data from different sources we have come to conclusion that insulin pen is the
most preferred mode of injecting insulin globally. Though the insulin syringes are still popular
it is ceding market share rapidly to insulin pen and pump. Currently insulin pen leads the
market segment but in the future insulin pump will dominate the market, as there is lot of
R&D going on for improving it. Insulin pen are popular in Europe and Japan while insulin
pumps are gaining popularity in US, fast replacing the dominance of insulin syringe in the
market. Even developing countries like India are adapting the insulin pen for its growth going
forward. Among future devices oral insulin and implantable insulin pump have bright future.
Key Questions Answered in this Report
What is the present and future market size of insulin pen, insulin pump, insulin syringe
and insulin jet injector globally?
What is insulin delivery devices market in 2007 and 2014 for Europe?
What is the present and future forecast of US, Europe and India insulin pen market?
What is the market share of companies in global pump market?
What is the present and future forecast of US insulin pump market?
Which company will control the US pump market in future?
What is oral insulin market of US?
What is the future of insulin patch, oral insulin and implantable insulin pump?
© Renub Research Page 2 of 14
Report Highlights
Globally by 2007 insulin pen controls more than 50 percent of market share in insulin
delivery devices market.
In 2006 insulin pen market share in Europe and Japan was more than 85 percent.
Global insulin pump and disposables market is expected to grow with a double digit
figure.
By 2009 companies Disetronic and MiniMed together are expected to control more than
70 percent of the insulin pump market globally.
US insulin pen is forecasted to grow at a CAGR of 11.96 percent from 2006 to 2010.
US insulin syringe market is expected to show a negative CAGR of -0.7 from 2007 to
2009.
US insulin pump market is expected to grow with a CAGR of 11.8 percent from 2002 to
2009.
European insulin pen market is expected to grow further but its market share is
expected to decline from 89.7 percent in 2007 to 70.6 percent in 2014.
Key Company Profiles
This section provides business overview and key financial information of the companies listed:
Novo Nordisk A/S, Sanofi-Aventis, Becton, Dickinson and Company, GlaxoSmithKline plc,
Amylin Pharmaceuticals, Inc., Merck & Co., Inc., Eli Lilly and Company.
Data Sources
Information and data in this report has been collected from various printable and non-
pintable sources like Magazines, Newspapers, Trade Journals, White papers, Online paid
databases, News websites Government Agencies and Trade associations.
© Renub Research Page 3 of 14
About Us
Renub Research is a leading Market Research and Information Analysis Company with
centers at Noida India and Roswell USA. We have more than 7 years of experience especially
in international Business-to-Business Researches, Surveys, Business and Consulting.
Throughout the years we have acquired expertise in most market sectors, including
Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial
Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive,
Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.
Our core team is comprised of an experienced people holding graduate, post graduate and
Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information
Technology, Environmental Science and many more. Our research help make the business
decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We
support many blue chip companies by providing them findings and perspectives across a wide
range of markets. Our research reports offer a blend of information insight, analysis and
forecasting that is essential in today’s ultra-competitive markets.
For more information on us or to view any of our sample work you can
mail us at info@renub.com
© Renub Research Page 4 of 14
Published
By
Renub Research
A–116B, Sector–27
Noida – 201301
Phone: +91-120-421-9822, 254-5750 (India)
+1-678-302-0700 (USA)
Fax : +91-120-424-9780
Email: info@renub.com
www.renub.com
© Insulin Delivery Devices Market Analysis and Future Forecast
Renub Research, 2009
Edition 1.0
All rights reserved. This publication is protected
by copyright. No part of it may be reproduced, stored
in a retrieval system or transmitted, in any form or by
any means, electronic mechanical, photocopying,
recording or otherwise without the prior written
permission of the publishers
© Renub Research Page 5 of 14
Table of Contents
1. Executive Summary
2. Global Insulin Market
2.1 Global Insulin Market – Growth Prospects
2.2 Global – Insulin Delivery Devices Market
3. Global Insulin Pens Market
3.1.1 Global – Insulin Pen Key Players
3.2 US Insulin Pen Market
3.3 Europe Insulin Delivery Devices & Insulin Pen Market
3.4 India Insulin Pen Market
3.5 Japan Insulin Pen Devices Market
4. Global Insulin Pumps Market
4.1 Global – Insulin Pump Key Players
4.2 US Insulin Pumps Market
4.2.1 Key Players
4.3 Outside US Insulin Pump Market
4.4 India Insulin Pump Market
4.5 Europe Insulin Pump - Key Companies
5. Global Insulin Syringe Market
5.1 US Insulin Syringe Market
6. Global Insulin Jet Injectors Market
6.1 US Insulin Jet Injectors Market
7. Future Insulin Devices
7.1 Insulin Patch
7.2 Oral Insulin
7.2.1 US Oral Insulin Market
7.3 Implantable Insulin Pump
8. Key Company Profiles
8.1 Novo Nordisk A/S
8.2 Sanofi-Aventis
8.3 Becton, Dickinson and Company
8.4 GlaxoSmithKline plc
8.5 Amylin Pharmaceuticals, Inc.
© Renub Research Page 6 of 14
8.6 Merck & Co., Inc.
8.7 Eli Lilly and Company
© Renub Research Page 7 of 14
List of Figures:
Figure 2-1: Global – Insulin Market (in Billion USD), 2005 – 2007
Figure 2-2: Global – Insulin Market (Billion USD), 2008 – 2012
Figure 3-3: Global – Key Players Insulin Pen Market Shares (Percent), 2006
Figure 3-4: US – Insulin Pens Market (Million USD), 2003 – 2006E
Figure 3-5: US – Forecast for Insulin Pens Market (Million USD), 2007 – 2010
Figure 3-7: Europe – Insulin Delivery Devices Market (USD Million), 2000, 2007 & 2014
Figure 3-8: Europe - Percentage of Insulin Units Delivered in Pen Devices (Percent), 1996, 2000, 2004,
2006 & 2007E
Figure 3-9: Europe - Insulin Pen Devices Market (Million USD), 2007 – 2014
Figure 3-10: Europe – Volume Share of Disposable Pens & Other Pens, (in Percent), 2006
Figure 3-12: India – Market Share of Normal Syringes & Pen Delivery Systems (in Percent), 2007
Figure 3-13: Japan – Insulin Pen Devices (Percent), 1996, 2000, 2004 & 2006
Figure 4-2: Global – Growth Rate of Insulin Pump and Disposables Market (in Percent), 2002 – 2009F
Figure 4-4: US – Insulin Pump and Disposables Market Growth Rate (in Percent), 2002 – 2009F
Figure 4-5: US - Pumps & Disposable Market Revenue (Million USD), 2002 – 2009F
Figure 4-8: US - Cumulative Number of Insulin (Type 1 Pump & Type 2 Pump) Sales (000’ Units) 2002 –
2009F
Figure 4-10: Global (Outside US) - Insulin Pump and Disposables Market (Million USD), 2002 -2009F
Figure 4-11: Global (Outside US) - Insulin Pump and Disposables Market (Percent), 2002 – 2009F
Figure 4-12: Global – Market Share of US and Outside US in the Insulin Pumps & Disposables Market (in
Percent), 2002 -2009F
Figure 4-13: India – Number of Insulin Pump Devices (Units), 2005E
Figure 4-14: India – Insulin Pump Market (INR Million), 2005
Figure 4-15: Europe – Key Companies (Medtronic, Distronic) Insulin Pump Market (Percent), 2003
Figure 5-2: US - Insulin Syringe Market (Million USD), 2003 – 2006E
Figure 5-3: US – Forecast for Insulin Syringe Market (Million USD), 2007 – 2010
Figure 6-3: US Insulin Jet Injectors Market (Million USD), 2003 – 2006E
Figure 7-1: US - Forecast for Oral Insulin Market (Million USD), 2007 – 2010
© Renub Research Page 8 of 14
List of Tables:
Table 4-1: Global – Key Companies Market Share of Insulin Pumps (in Percent), 2002 – 2009F
Table 4-3: US – Key Companies Market Share of Total Pump Units Sold (New and Replacement) (in
Percent), 2002 – 2009F
Table 8-1: Novo Nordisk A/S - Key Financials (Million USD), 2006 – 2008
Table 8-2: Sanofi-Aventis - Key Financials (Million USD), 2006 – 2008
Table 8-3: Becton, Dickinson and Company - Key Financials (Million USD), 2006 – 2008
Table 8-4: GlaxoSmithKline plc - Key Financials (Million USD), 2006 – 2008
Table 8-5: Amylin Pharmaceuticals, Inc. - Key Financials (Million USD), 2006 – 2008
Table 8-6: Merck & Co., Inc. - Key Financials (Million USD), 2006 – 2008
© Renub Research Page 9 of 14
Order Form
Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact
Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780
Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to
info@renub.com
Format
Report Title: Insulin Delivery Devices Market Analysis and Future Forecast
Single Users Hard Copy CD-Rom Global Site License
(Email from publisher) (Mail Delivery) (Mail Delivery) (Multiple Users License)
US$ 850 US$ 850 US$ 850 US$ 1,100
For ordering this report: Three easy ways to place your order:
1) Order online by Credit Card (Visa, MasterCard, etc.):
http://renub.com/reports/showdetails.aspx?id=14
2) Order by Wire Transfer:
http://renub.com/reports/wiretransfer.aspx?id=14&pid=1052
To pay by Wire Transfer, please, fill in your contact details in the form below:
© Renub Research Page 10 of 14
Bank Details
Account Name: Renub Research
A/C No.: 109102000023296
Name of Bank: IDBI Bank Ltd.
Swift Code: IBKLINBB010
Bank Address: 4th Floor
Indian Red Cross Building
1 Red Cross Road
Opposite Parliament Street
New Delhi – 110001
India
Contact Information
First Name: Last Name:
Email:
Job Title:
Company:
Address:
City:
Postal/Zip Code:
Country:
Phone:
Mobile:
Fax:
Report Format:
Your message:
© Renub Research Page 11 of 14
3) Order by Check
Please post the check accompanied by this form, to:
Company Address: Renub Research
A -116B
Sector -27
Noida - 201301
Uttar Pradesh
India
Phone: +91-120-421-9822, 424-9780
For free Sample copy report or to view any of our sample work please contact us at
info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)
Follow Us
Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090
LinkedIn: http://www.linkedin.com/company/renub-research
Twitter: http://twitter.com/RenubResearch
© Renub Research Page 12 of 14
Our Partial List of Clients
Redbus Bain
Becton Dickinson WAKE Technology Services, Inc.
Pfizer PSS World Medical
Intercell Relypsa
Sanofi Pasteur C&K components
Stanford Burgess Konkuk University
Pequot Capital Resonetics
DMI Samsung
Transgene S.A. SEKISUI MEDICAL CO. LTD.
ixia communications Plentyoffish Media INC
Toyota Tsusho Amercia Inc. Arthur D Little Gmbh
National Health Research Institutes Morgan Stanley
Abbott Diabetes Care Takeda Pharmaceutical Corporation
Corning Incorporated - Life Sciences Hokkai School of Commerce
L.E.K. Consulting GmbH Ministry of Manpower Singapore
Syntiron GenOmind, LLC.
MediVas LLC Goldman Sachs & Co
Credit Suisse NTT Advanced Technology
Dune Medical Tokyo Womens Medical University
QIAGEN The Chemo-Sero-Therapeutic Research
Inje University Trade Council of Iceland
Mapp Biopharmaceutical Jpmorgan, Ets Trading
Institute for Information Industry GE Healthcare IT
NorDiag ASA ixia communications
Rep e Inv Medicas SA de
Innogenetics
© Renub Research Page 13 of 14
Disclaimer
Most of the information available in this report is within the public domain. The submitting
authors or other copyright holders retain rights for reproduction or redistribution. All persons
reproducing or redistributing this information are expected to adhere to the terms and
constraints invoked by the copyright holder. Such protected material, however, may be used
under the terms of "fair use” as defined in the copyright laws, which generally permit use for
non-commercial educational purposes such as teaching, research, criticism, and news
reporting.
With respect to documents available, neither the company nor any of its employees makes
any warranty, express or implied, including the warranties of merchantability and fitness for
a particular purpose, or assumes any legal liability or responsibility for the accuracy,
completeness, or usefulness of any information, apparatus, product, or process disclosed, or
represents that its use would not infringe privately owned rights.
Unless otherwise stated, the copyright, database rights, and similar rights in all material
published on this manual is solely owned by Renub Research. You are permitted to print or
download extracts from this material for your personal use only. None of this material may be
used for any commercial or public use.
No part of this manual or any material appearing may be reproduced, stored in or transmitted
on any other Web site without written permission of www.renub.com and any payments of a
specified fee. Requests to republish any material may be sent to us at info@renub.com.
© Renub Research Page 14 of 14